cardio-symposium - lectures online

Managing blood glucose lowering in the context of CAD: An independent view
27-Aug-12 , Munich, Germany
Factor Xa inhibition in cardiology – a new era in the prevention of cardiovascular outcomes
19-Apr-12 , Dubai, United Arab Emirates
CVD risk prediction and management in patients with diabetes
06-Dec-11 , Dubai, United Arab Emirates
4th Annual Meeting of the D&CVD EASD Study Group - Day 3
29-Oct-11 , Munich, Germany
4th Annual Meeting of the D&CVD EASD Study Group - Day 2
28-Oct-11 , Munich, Germany
4th Annual Meeting of the D&CVD EASD Study Group - Day 1
27-Oct-11 , Munich, Germany
Highly purified omega-3 fatty acid ethyl-esters: 
What do the data tell us?
30-Aug-11 , Paris, France
Diabetes and cardiovascular disease: effects of insulin and GLP-1 analogues
31-Aug-10 , Stockholm, Sweden
Improving outcomes in patients at risk of thromboembolic diseases ... Working toward a clot-free future
30-Aug-10 , Stockholm, Sweden
Highly purified omega-3 fatty acid ethyl-esters: Adding benefits in cardiovascular risk prevention
29-Aug-10 , Stockholm, Sweden
What pre-clinical and clinical results have taught us about the PACCOCATH drug-eluting balloon coating technology
25-May-10 , Paris, France
Wake up to sleep apnoea
18-Oct-09 , Montreal, Canada
CVD - the Need for Early Intervention
18-Oct-09 , Montreal, Canada
What more can we achieve beyond mono and combination therapy for hypertension management?
29-Aug-09 , Barcelona, Spain
Highly purified omega-3 fatty acid ethyl-esters: proven effects and future prospects
01-Sep-09 , Barcelona, Spain
Diabetes and the heart: state-of-the-art treatment strategies
01-Sep-09 , Barcelona, Spain
Management of high-risk patients with type 2 diabetes – a collaborative approach
01-Sep-09 , Barcelona, Spain
Linking sleep apnoea, cardiology and diabetes: what you don't know may surprise you!
31-Aug-09 , Barcelona, Spain